Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Philip Morris
PM
|
+$339M |
| 3 |
DuPont de Nemours
DD
|
+$270M |
| 4 |
Altria Group
MO
|
+$268M |
| 5 |
Fox Class A
FOXA
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$513M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$362M |
| 3 |
Merck
MRK
|
+$350M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$277M |
| 5 |
Pfizer
PFE
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 12.8% |
| 3 | Consumer Discretionary | 11.91% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HYB
2226
DELISTED
New America High Income Fund, Inc.
HYB
| $3.25M | ﹤0.01% |
381,947
-60,805
| -14% | -$504K |
|
2227
Asbury Automotive
ABG
$4.31B
| $3.24M | ﹤0.01% |
46,666
-4,413
| -9% | -$307K |
|
|
AGD
2228
abrdn Global Dynamic Dividend Fund
AGD
$318M
| $3.23M | ﹤0.01% |
341,381
+52,048
| +18% | +$493K |
|
2229
Madrigal Pharmaceuticals
MDGL
$10.8B
| $3.23M | ﹤0.01% |
+25,813
| New | +$3.21M |
|
|
RTEC
2230
DELISTED
Rudolph Technologies Inc
RTEC
| $3.23M | ﹤0.01% |
141,451
-12,878
| -8% | -$283K |
|
2231
Cavco Industries
CVCO
$4.22B
| $3.22M | ﹤0.01% |
27,425
+1,699
| +7% | +$232K |
|
|
LDL
2232
DELISTED
Lydall, Inc.
LDL
| $3.22M | ﹤0.01% |
137,429
+15,460
| +13% | +$391K |
|
|
RUTH
2233
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $3.22M | ﹤0.01% |
125,896
-5,073
| -4% | -$124K |
|
2234
Designer Brands
DBI
$307M
| $3.22M | ﹤0.01% |
144,871
+11,709
| +9% | +$307K |
|
2235
Banco Santander Chile
BSAC
$16.3B
| $3.21M | ﹤0.01% |
107,741
+5,486
| +5% | +$171K |
|
2236
ICF International
ICFI
$1.46B
| $3.21M | ﹤0.01% |
42,124
-11,778
| -22% | -$831K |
|
|
CVET
2237
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.2M | ﹤0.01% |
+100,575
| New | +$3.57M |
|
|
STK
2238
Columbia Seligman Premium Technology Growth Fund
STK
$867M
| $3.19M | ﹤0.01% |
158,863
+4,373
| +3% | +$84.6K |
|
2239
Cohen & Steers Infrastructure Fund
UTF
$3.11B
| $3.19M | ﹤0.01% |
130,072
-13,329
| -9% | -$307K |
|
|
HEQ
2240
John Hancock Hedged Equity & Income Fund
HEQ
$137M
| $3.19M | ﹤0.01% |
216,490
+21,855
| +11% | +$314K |
|
|
ANAT
2241
DELISTED
American National Group, Inc. Common Stock
ANAT
| $3.18M | ﹤0.01% |
26,347
+5,307
| +25% | +$729K |
|
2242
Sinclair Inc
SBGI
$992M
| $3.18M | ﹤0.01% |
82,547
+12,299
| +18% | +$412K |
|
|
CTRL
2243
DELISTED
Control4 Corporation
CTRL
| $3.17M | ﹤0.01% |
187,484
-4,102
| -2% | -$74K |
|
|
AIF
2244
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $3.17M | ﹤0.01% |
216,035
+14,265
| +7% | +$207K |
|
|
PES
2245
DELISTED
Pioneer Energy Services Corp.
PES
| $3.17M | ﹤0.01% |
1,788,615
-230,462
| -11% | -$397K |
|
|
PLAN
2246
DELISTED
Anaplan, Inc.
PLAN
| $3.16M | ﹤0.01% |
+80,204
| New | +$2.7M |
|
|
MDRX
2247
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.16M | ﹤0.01% |
330,816
+34,518
| +12% | +$381K |
|
|
TECX
2248
Tectonic Therapeutic
TECX
$529M
| $3.15M | ﹤0.01% |
11,926
-18
| -0.2% | -$3.29K |
|
2249
Pediatrix Medical
MD
$2.18B
| $3.15M | ﹤0.01% |
116,073
+15,383
| +15% | +$516K |
|
2250
Vera Bradley
VRA
$97M
| $3.15M | ﹤0.01% |
237,805
+10,755
| +5% | +$110K |
|
Similar funds
Invesco's Q1 2019 Portfolio in Review
As of Q1 2019, Invesco held 3,988 positions worth $297B, up 14% from $261B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2019 filing shows 172 new, 1,740 increased, 1,658 reduced and 285 closed positions. Its largest new stake was Fox Class A: 4,126,302 shares worth $151M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Invesco's largest Q1 2019 buy was Fox Class A: 4,126,302 shares worth $151M.
- Invesco added most to Apple in Q1 2019, an estimated $381M increase.
- Invesco's biggest Q1 2019 reduction was Merck, cutting an estimated $350M.
- Invesco fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $513M.
- Invesco's ten largest holdings make up 17% of its $297B portfolio in Q1 2019.
- Invesco opened 172 new positions and closed 285 in Q1 2019.
- Invesco's portfolio value rose 14% quarter-over-quarter to $297B.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.